The future treatment of Parkinson’s Disease has undergone tremendous development in recent years. Now, a breakthrough in research has emerged, delivering the strongest results for both side-effect-free and long-lasting treatment effects. Aarhus, Denmark – The results were just published in Nature Communications under the title “Enhanced production of mesencephalic...
treatment News
Baton Rouge, Louisiana – A new partnership between a Pennington Biomedical physician-researcher at the Metamor Institute and an LSU School of Medicine oncologist has already saved women’s lives in southeast Louisiana. More than 60,000 women are diagnosed with endometrial cancer each year, a number that includes women much younger than...
Brighton, UK – New research by the University of Sussex could help to increase life expectancy and improve treatment for an aggressive brain cancer, which impacts thousands of people every year in the UK, and hundreds of thousands worldwide. In the study, published in the journal of Advanced Science, researchers have...
Boulder, Colorado – Imagine your greatest fear. Now, write it down and tell it in first-person, as if it’s happening right now. Vividly describe what it looks, sounds, smells, tastes and feels like. Don’t hold back. Such an exercise could be daunting for anyone, dredging up feelings we try to...
North Bethesda, Maryland – A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver....
Okayama, Japan – Biliary tract cancers (BTCs) including cholangiocarcinoma (CCA) and gallbladder cancer (GBC) are becoming more prevalent globally. An effective chemotherapeutic agent for the treatment of BTCs is gemcitabine. Other novel molecular targeted drugs have also been developed; however, they are only effective at treating a few cases of...
Milan, Italy – New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug, pembrolizumab, to chemotherapy before and after surgery for breast cancer leads to better outcomes for patients regardless of their age or menopausal status. The findings, presented at the 14th European Breast Cancer...
Edmonton, Canada – A University of Alberta team has developed a new step to improve the process for creating insulin-producing pancreatic cells from a patient’s own stem cells, bringing the prospect of injection-free treatment closer for people with diabetes. The researchers take stem cells from a single patient’s blood and...
MINNEAPOLIS – Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released today, March 4, 2024. The study will be presented at the American Academy of Neurology’s...
Valencia, Spain – The research focused on evaluating the efficacy of bevacizumab (BVZ) in treating glioblastoma (GBM). This drug is designed to inhibit the formation of new blood vessels in the tumour. However, according to Dr María del Mar Álvarez-Torres from the Universitat Politècnica de València, the efficacy of this...